Phase 3 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have been formally diagnosed with schizophrenia through a thorough psychiatric assessment, using recognised diagnostic guidelines (DSM-5), confirmed by a structured interview called the MINI.
- Your symptoms must fall within a specific range on a standard schizophrenia rating scale called the PANSS, with a total score between 80 and 120 (confirm with trial site).
- Your overall illness severity must be rated at least 4 (meaning "moderately ill") on a standard scale used by clinicians called the CGI-S (confirm with trial site).
Who may not be able to join:
- You may not be eligible if you have been diagnosed with any other major psychiatric condition (besides schizophrenia) within the past 12 months.
- You may not be eligible if you have only recently been diagnosed with schizophrenia or if this would be your first time receiving treatment for it.
- You may not be eligible if you have any significant ongoing or past physical health conditions (confirm with trial site for details on what qualifies).
- There are additional eligibility requirements set by the trial's rules that are not listed here, so further checks will be needed (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in Positive and Negative Syndrome Scale (PANSS) total score; Number of participants with treatment-emergent adverse events (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.